MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 29, 2006; DOI: 10.1124/mol.106.028456


0026-895X/07/7101-47-60$20.00
Mol Pharmacol 71:47-60, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.028456v1
71/1/47    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, T. M.
Right arrow Articles by Clark, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, T. M.
Right arrow Articles by Clark, R. B.

Characterization of beta2-Adrenergic Receptor Dephosphorylation: Comparison with the Rate of Resensitization

Tuan M. Tran, Jacqueline Friedman, Faiza Baameur, Brian J. Knoll, Robert H. Moore, and Richard B. Clark

Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Medical School, Houston, Texas (T.M.T., J.F., F.B., R.B.C.); Department of Pediatrics, Baylor College of Medicine, Houston, Texas (R.H.M.); and Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Texas (B.J.K.)

Dephosphorylation of the cyclic AMP-dependent protein kinase (PKA) site phosphoserine 262 and the G protein-coupled receptor kinase (GRK) site phosphoserines 355 and 356 of the beta2-adrenergic receptor (beta2AR) were characterized in both intact human embryonic kidney 293 cells and subcellular fractions and were correlated with the rate of resensitization of isoproterenol stimulation of adenylyl cyclase after treatment with isoproterenol and blockade by antagonist. Dephosphorylation of the PKA site after stimulation with 300 pM isoproterenol occurred with a t1/2 of 9 min (k = 0.08 ± 0.016/min) in intact cells in the absence of internalization. Dephosphorylation of the GRK sites in intact cells after treatment with 1.0 µM isoproterenol for 5 min exhibited a lag phase of {approx} 5 min, after which dephosphorylation proceeded slowly with a t1/2 of 18 min (k = 0.039 ± 0.006/min). Consistent with the slow rate of GRK site dephosphorylation, the phosphatase inhibitors calyculin A and okadaic acid failed to augment phosphorylation in intact cells during continuous agonist stimulation indicating that GRK site dephosphorylation was minimal. However, both inhibited dephosphorylation of the GRK sites after the addition of antagonist. Slow GRK site dephosphorylation after antagonist treatment was also demonstrated by the relative stability of internalized phosphorylated beta2AR in cells as observed both by immunofluorescence microscopy using a phospho-site-specific antibody and by studies of the subcellular localization of the GRK-phosphorylated beta2AR on sucrose gradients that revealed nearly equivalent levels of GRK site phosphorylation in the plasma membrane and vesicular fractions. In addition, dephosphorylation of the GRK sites by intrinsic phosphatase activity occurred only in the heavy vesicle fractions. In contrast to the slow rates of dephosphorylation, the rate of resensitization of isoproterenol stimulation of adenylyl cyclase was 5- and 10-fold faster (k = 0.43 ± 0.009/min; t1/2 = 1.6 min), than PKA and GRK site dephosphorylation, respectively, clearly dissociating the rapid phase of resensitization (0-5 min) from dephosphorylation.


Received for publication June 29, 2006.

Accepted for publication September 28, 2006.

Address correspondence to: Richard B. Clark, Dept. of Integrative Biology and Pharmacology, University of Texas Health Science Center Houston, Medical School, 6431 Fannin, Houston, TX. E-mail: richard.b.clark{at}uth.tmc.edu




This article has been cited by other articles:


Home page
Cancer Res.Home page
X. He, L. Fang, J. Wang, Y. Yi, S. Zhang, and X. Xie
Bryostatin-5 Blocks Stromal Cell-Derived Factor-1 Induced Chemotaxis via Desensitization and Down-regulation of Cell Surface CXCR4 Receptors
Cancer Res., November 1, 2008; 68(21): 8678 - 8686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Bruss, W. Richter, K. Horner, S.-L. C. Jin, and M. Conti
Critical Role of PDE4D in {beta}2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts
J. Biol. Chem., August 15, 2008; 283(33): 22430 - 22442.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
W. Xin, T. M. Tran, W. Richter, R. B. Clark, and T. C. Rich
Roles of GRK and PDE4 Activities in the Regulation of {beta}2 Adrenergic Signaling
J. Gen. Physiol., March 31, 2008; 131(4): 349 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Violin, L. M. DiPilato, N. Yildirim, T. C. Elston, J. Zhang, and R. J. Lefkowitz
{beta}2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics
J. Biol. Chem., February 1, 2008; 283(5): 2949 - 2961.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. H. So, V. Verma, B. F. O'Dowd, and S. R. George
Desensitization of the Dopamine D1 and D2 Receptor Hetero-Oligomer Mediated Calcium Signal by Agonist Occupancy of Either Receptor
Mol. Pharmacol., August 1, 2007; 72(2): 450 - 462.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics